home.social

#biopsy — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biopsy, aggregated by home.social.

  1. Phew, that's a relief. 3 weeks ago I had 2 painful biopsies to check if the lesions on my tongue were a return of the cancer that was surgically removed in 2022. Turns out they're just stubborn mouth ulcers. And...breathe...
    #tongue #cancer #biopsy

  2. Phew, that's a relief. 3 weeks ago I had 2 painful biopsies to check if the lesions on my tongue were a return of the cancer that was surgically removed in 2022. Turns out they're just stubborn mouth ulcers. And...breathe...
    #tongue #cancer #biopsy

  3. Phew, that's a relief. 3 weeks ago I had 2 painful biopsies to check if the lesions on my tongue were a return of the cancer that was surgically removed in 2022. Turns out they're just stubborn mouth ulcers. And...breathe...
    #tongue #cancer #biopsy

  4. Phew, that's a relief. 3 weeks ago I had 2 painful biopsies to check if the lesions on my tongue were a return of the cancer that was surgically removed in 2022. Turns out they're just stubborn mouth ulcers. And...breathe...
    #tongue #cancer #biopsy

  5. Phew, that's a relief. 3 weeks ago I had 2 painful biopsies to check if the lesions on my tongue were a return of the cancer that was surgically removed in 2022. Turns out they're just stubborn mouth ulcers. And...breathe...
    #tongue #cancer #biopsy

  6. 🔬 Biopsy smart, not routine.

    Knowing when to biopsy—and when not to— can change diagnosis, management, and outcomes in upper GI endoscopy.

    From Barrett’s protocols to linitis plastica sampling—precision matters.

    #GastroAGI #Endoscopy #UpperGI #Biopsy #Gastroenterology #GIEndoscopy #MedicalEducation

  7. A standard practice for colonoscopy completion

    Background and objectives Terminal ileum intubation is considered the completion step of colonoscopy and is usually performed to…
    #NewsBeep #News #Health #AbdominalPain #Anemia #AU #Australia #biopsy #Cancer #Colonoscopy #Diagnostic #Diarrhea #Pain
    newsbeep.com/au/507591/

  8. A standard practice for colonoscopy completion

    Background and objectives Terminal ileum intubation is considered the completion step of colonoscopy and is usually performed to…
    #NewsBeep #News #Health #AbdominalPain #Anemia #AU #Australia #biopsy #Cancer #Colonoscopy #Diagnostic #Diarrhea #Pain
    newsbeep.com/au/507591/

  9. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  10. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  11. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  12. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  13. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  14. Custom Breast Cancer Screening. A custom program led to fewer tests, less radiation exposure, but no increased risk of missing a treatable cancer. #breast #cancer #screening #genetics #biopsy
    instagram.com/p/DTdsdqLjmIp/

  15. Custom Breast Cancer Screening. A custom program led to fewer tests, less radiation exposure, but no increased risk of missing a treatable cancer. #breast #cancer #screening #genetics #biopsy
    instagram.com/p/DTdsdqLjmIp/

  16. Elderly neighbor had a cool biopsy of a lung. They use a little robot coming in through the airways. The robot picked up some tissue and dropped off a couple of tiny pieces of metal.

    They call these "targets". They allow superior targeting of tumors for radiation treatment.

    No, they don't go pick them up again if the biopsy comes back negative, 🙂.

    #robot #biopsy #medicine #radiation

  17. Elderly neighbor had a cool biopsy of a lung. They use a little robot coming in through the airways. The robot picked up some tissue and dropped off a couple of tiny pieces of metal.

    They call these "targets". They allow superior targeting of tumors for radiation treatment.

    No, they don't go pick them up again if the biopsy comes back negative, 🙂.

    #robot #biopsy #medicine #radiation

  18. Elderly neighbor had a cool biopsy of a lung. They use a little robot coming in through the airways. The robot picked up some tissue and dropped off a couple of tiny pieces of metal.

    They call these "targets". They allow superior targeting of tumors for radiation treatment.

    No, they don't go pick them up again if the biopsy comes back negative, 🙂.

    #robot #biopsy #medicine #radiation

  19. Elderly neighbor had a cool biopsy of a lung. They use a little robot coming in through the airways. The robot picked up some tissue and dropped off a couple of tiny pieces of metal.

    They call these "targets". They allow superior targeting of tumors for radiation treatment.

    No, they don't go pick them up again if the biopsy comes back negative, 🙂.

    #robot #biopsy #medicine #radiation

  20. Elderly neighbor had a cool biopsy of a lung. They use a little robot coming in through the airways. The robot picked up some tissue and dropped off a couple of tiny pieces of metal.

    They call these "targets". They allow superior targeting of tumors for radiation treatment.

    No, they don't go pick them up again if the biopsy comes back negative, 🙂.

    #robot #biopsy #medicine #radiation